154 related articles for article (PubMed ID: 36571111)
1. MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.
van der Vis JJ; Prasse A; Renzoni EA; Stock CJW; Caliskan C; Maher TM; Bonella F; Borie R; Crestani B; Petrek M; Wuyts WA; Wind AE; Molyneaux PL; Grutters JC; van Moorsel CHM
Respirology; 2023 May; 28(5):455-464. PubMed ID: 36571111
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment.
Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P
Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872
[TBL] [Abstract][Full Text] [Related]
3. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias.
van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH
Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835
[TBL] [Abstract][Full Text] [Related]
4. The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis.
Wu X; Li W; Luo Z; Chen Y
Sci Rep; 2021 Dec; 11(1):24007. PubMed ID: 34907291
[TBL] [Abstract][Full Text] [Related]
5. Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF.
Bonella F; Campo I; Zorzetto M; Boerner E; Ohshimo S; Theegarten D; Taube C; Costabel U
Orphanet J Rare Dis; 2021 Feb; 16(1):111. PubMed ID: 33639995
[TBL] [Abstract][Full Text] [Related]
6. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
[TBL] [Abstract][Full Text] [Related]
7. Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis.
Peljto AL; Zhang Y; Fingerlin TE; Ma SF; Garcia JG; Richards TJ; Silveira LJ; Lindell KO; Steele MP; Loyd JE; Gibson KF; Seibold MA; Brown KK; Talbert JL; Markin C; Kossen K; Seiwert SD; Murphy E; Noth I; Schwarz MI; Kaminski N; Schwartz DA
JAMA; 2013 Jun; 309(21):2232-9. PubMed ID: 23695349
[TBL] [Abstract][Full Text] [Related]
8. MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.
Juge PA; Solomon JJ; van Moorsel CHM; Garofoli R; Lee JS; Louis-Sydney F; Rojas-Serrano J; González-Pérez MI; Mejia M; Buendia-Roldán I; Falfán-Valencia R; Ambrocio-Ortiz E; Manali E; Papiris SA; Karageorgas T; Boumpas D; Antoniou KM; Sidiropoulos P; Trachalaki A; van der Vis JJ; Jamnitski A; Grutters JC; Kannengiesser C; Borie R; Kawano-Dourado L; Wemeau-Stervinou L; Flipo RM; Nunes H; Uzunhan Y; Valeyre D; Saidenberg-Kermanac'h N; Boissier MC; Richez C; Schaeverbeke T; Doyle T; Wolters PJ; Debray MP; Boileau C; Porcher R; Schwartz DA; Crestani B; Dieudé P
Semin Arthritis Rheum; 2021 Oct; 51(5):996-1004. PubMed ID: 34411838
[TBL] [Abstract][Full Text] [Related]
9. Radiological Assessment in Idiopathic Pulmonary Fibrosis (IPF) Patients According to MUC5B Polymorphism.
Cocconcelli E; Bernardinello N; Giraudo C; Castelli G; Greco C; Polverosi R; Saetta M; Spagnolo P; Balestro E
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555528
[TBL] [Abstract][Full Text] [Related]
10.
Doubkova M; Kriegova E; Littnerova S; Schneiderova P; Sterclova M; Bartos V; Plackova M; Zurkova M; Bittenglova R; Lostaková V; Siskova L; Lisa P; Suldova H; Doubek M; Psikalova J; Snizek T; Musilova P; Vasakova M
Ther Adv Respir Dis; 2021; 15():17534666211042529. PubMed ID: 34515605
[TBL] [Abstract][Full Text] [Related]
11. Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations.
Zhu QQ; Zhang XL; Zhang SM; Tang SW; Min HY; Yi L; Xu B; Song Y
Medicine (Baltimore); 2015 Oct; 94(43):e1901. PubMed ID: 26512610
[TBL] [Abstract][Full Text] [Related]
12. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
[TBL] [Abstract][Full Text] [Related]
13. Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.
Fadista J; Kraven LM; Karjalainen J; Andrews SJ; Geller F; ; Baillie JK; Wain LV; Jenkins RG; Feenstra B
EBioMedicine; 2021 Mar; 65():103277. PubMed ID: 33714028
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of common genetic variants in idiopathic pulmonary fibrosis survival.
Mota PC; Soares ML; Vasconcelos CD; Ferreira AC; Lima BA; Manduchi E; Moore JH; Melo N; Novais-Bastos H; Pereira JM; Guimarães S; Moura CS; Marques JA; Morais A
J Mol Med (Berl); 2022 Sep; 100(9):1341-1353. PubMed ID: 35986225
[TBL] [Abstract][Full Text] [Related]
15. The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort.
Wang H; Zhuang Y; Peng H; Cao M; Li Y; Xu Q; Xin X; Zhou K; Liang G; Cai H; Dai J
Sci Rep; 2019 Oct; 9(1):15307. PubMed ID: 31653936
[TBL] [Abstract][Full Text] [Related]
16. Interaction between the promoter
Stock CJ; Conti C; Montero-Fernandez Á; Caramori G; Molyneaux PL; George PM; Kokosi M; Kouranos V; Maher TM; Chua F; Rice A; Denton CP; Nicholson AG; Wells A; Sestini P; Renzoni EA
Thorax; 2020 Oct; 75(10):901-903. PubMed ID: 32580994
[TBL] [Abstract][Full Text] [Related]
17. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ
Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
[TBL] [Abstract][Full Text] [Related]
19. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.
Lee MG; Lee YH
Inflamm Res; 2015 Jun; 64(6):463-70. PubMed ID: 25926289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
